Skip to main content
Fig. 1 | Antimicrobial Resistance & Infection Control

Fig. 1

From: Impact of the COVID-19 pandemic on extended-spectrum β-lactamase producing Escherichia coli in urinary tract and blood stream infections: results from a nationwide surveillance network, Finland, 2018 to 2022

Fig. 1

The annual proportion of extended-spectrum β-lactamase-producing Escherichia coli in blood and urine E. coli isolates among males and females, Finland, 2018–2022. AAD: average annual decrease; CI: compatibility interval; ESBL+: extended-spectrum β-lactamase-producing Escherichia coli; RelD: relative decrease

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us